These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2309647)

  • 21. Effect of L-carnitine supplementation in hemodialysis patients.
    Veselá E; Racek J; Trefil L; Jankovy'ch V; Pojer M
    Nephron; 2001 Jul; 88(3):218-23. PubMed ID: 11423752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic adaptive changes of the serum carnitine esters during and after L-carnitine supplementation in patients with maintenance haemodialysis.
    Bene J; Csiky B; Komlosi K; Sulyok E; Melegh B
    Scand J Clin Lab Invest; 2011 Jul; 71(4):280-6. PubMed ID: 21366497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Red blood cell sodium transport and phosphate release in uremia.
    Walter U; Becht E
    Nephron; 1983; 34(1):35-41. PubMed ID: 6304546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of L-carnitine supplementation on red blood cells deformability in hemodialysis patients.
    Nikolaos S; George A; Telemachos T; Maria S; Yannis M; Konstantinos M
    Ren Fail; 2000 Jan; 22(1):73-80. PubMed ID: 10718283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in erythrocyte calcium and potassium in patients during HD and CAPD.
    Paraskevopoulos A; Agroyannis B; Kopelias L; Tzanatos E; Tsomi A; Dalamanga A; Katsoudas S; Petras D; Voudiclari S
    Int J Artif Organs; 2000 Nov; 23(11):750-3. PubMed ID: 11132019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.
    Miyata T; van Ypersele de Strihou C; Imasawa T; Yoshino A; Ueda Y; Ogura H; Kominami K; Onogi H; Inagi R; Nangaku M; Kurokawa K
    Kidney Int; 2001 Dec; 60(6):2351-9. PubMed ID: 11737610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a positive association between serum carnitine and free testosterone levels in uremic men with hemodialysis.
    Sakai K; Fukami K; Yamagishi S; Kaida Y; Adachi T; Ando R; Manabe R; Otsuka A; Sugi K; Ueda S; Okuda S
    Rejuvenation Res; 2013 Jun; 16(3):200-5. PubMed ID: 23488553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carnitine depletion as a probable cause of hyperlipidemia in uremic patients on maintenance hemodialysis.
    Maebashi M; Imamura A; Yoshinaga K; Sato T; Funyu T; Ishidoya Y; Hirayama N
    Tohoku J Exp Med; 1983 Jan; 139(1):33-42. PubMed ID: 6836557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of L-carnitine on arrhythmias during hemodialysis.
    Suzuki Y; Narita M; Yamazaki N
    Jpn Heart J; 1982 May; 23(3):349-59. PubMed ID: 6178854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Protective role of carnitine in acetate metabolism of patients with uremia treated by hemodialysis].
    Wanic-Kossowska M
    Pol Arch Med Wewn; 1997 Jun; 97(6):534-40. PubMed ID: 9441289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects.
    Golper TA; Wolfson M; Ahmad S; Hirschberg R; Kurtin P; Katz LA; Nicora R; Ashbrook D; Kopple JD
    Kidney Int; 1990 Nov; 38(5):904-11. PubMed ID: 2266674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative damage during hemodialysis using a vitamin-E-modified dialysis membrane: a preliminary characterization.
    Buoncristiani U; Galli F; Rovidati S; Albertini MC; Campus G; Canestrari F
    Nephron; 1997; 77(1):57-61. PubMed ID: 9380239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carnitine and carnitine esters in acute renal failure.
    Wanner C; Riegel W; Schaefer RM; Hörl WH
    Nephrol Dial Transplant; 1989; 4(11):951-6. PubMed ID: 2516886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-carnitine deficiency and red blood cell mechanical impairment in beta-thalassemia major.
    Toptas B; Baykal A; Yesilipek A; Isbir M; Kupesiz A; Yalcin O; Baskurt OK
    Clin Hemorheol Microcirc; 2006; 35(3):349-57. PubMed ID: 16899956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
    Sakurauchi Y; Matsumoto Y; Shinzato T; Takai I; Nakamura Y; Sato M; Nakai S; Miwa M; Morita H; Miwa T; Amano I; Maeda K
    Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of autofluorescence of red blood cells (RbCs) in uremic patients as a marker of oxidative damage.
    Stoya G; Klemm A; Baumann E; Vogelsang H; Ott U; Linss W; Stein G
    Clin Nephrol; 2002 Sep; 58(3):198-204. PubMed ID: 12356188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of different carnitine levels for improving the prognosis of patients undergoing hemodialysis.
    Zhang YM; Zhuo L; Hu J; Cui G; Zhang L; Zhang XL; Li WG
    Ren Fail; 2016 Nov; 38(10):1654-1658. PubMed ID: 27758157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carnitine replacement in end-stage renal disease and hemodialysis.
    Calvani M; Benatti P; Mancinelli A; D'Iddio S; Giordano V; Koverech A; Amato A; Brass EP
    Ann N Y Acad Sci; 2004 Nov; 1033():52-66. PubMed ID: 15591003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered carnitine metabolism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation.
    Murphy WJ; Steiber A; Connery GC; Carder J; Spry L; Hoppel C
    Nephrol Dial Transplant; 2012 Jan; 27(1):304-10. PubMed ID: 21765185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
    Reuter SE; Faull RJ; Ranieri E; Evans AM
    Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.